abstract |
The present invention relates to isoxazol-pyridine derivatives of the formula I (see formula (I)) in which X, from R1 to R6 have the meanings defined in claim 1. These compounds are active at the receptor binding site GABA A5 and are useful for the treatment of cognitive disorders, for example Alzheimer's disease. |